Browsing: Nordisk

Investing.com — Novo Nordisk (CSE:) has been placed on JPMorgan’s Catalyst Watch list, signaling heightened anticipation as the company approaches…

Investing.com — Bank of America (BofA) adjusted its price objective for Novo Nordisk (NYSE:) shares to DKK1075 from the previous…

By Maggie Fick and Patrick Wingrove LONDON/NEW YORK (Reuters) – As Eli Lilly (NYSE:)’s weight-loss drug Zepbound gains ground in…

By Ahmed Aboulenein WASHINGTON (Reuters) -Senator Bernie Sanders on Wednesday expressed confidence that Novo Nordisk (NYSE:) can be convinced to…

LONDON (Reuters) – Shares in Novo Nordisk (NYSE:), maker of the wildly popular obesity drug Wegovy, were down 1.9% on…

Novo Nordisk investors appeared unperturbed Thursday by a critical Harvard report that linked weight loss drugs to a rare eye…

By Andrew Silver SHANGHAI (Reuters) – Novo Nordisk (NYSE:) is facing the prospect of intensifying competition in the promising Chinese…

BAGSVÆRD, Denmark – Novo Nordisk (NYSE:), a global healthcare company, has announced its agreement to purchase Cardior Pharmaceuticals for up…